Literature DB >> 6367329

Insulin-like growth factor I in the dog: a study in different dog breeds and in dogs with growth hormone elevation.

J E Eigenmann, D F Patterson, J Zapf, E R Froesch.   

Abstract

A radioimmunoassay (RIA) devised for the measurement of human insulin-like growth factor I (IGF I) was employed for the measurement of canine IGF I. Canine IGF I was extracted from plasma specimens by gel chromatography. Columns were eluted with 1 M acetic acid and the fractions representing the 55 to 85% bed volume were pooled, lyophilized and reconstituted with assay buffer. Serial dilutions of canine IGF I from both normal and acromegalic dogs when added to the RIA system gave a similar displacement pattern of human [125I]IGF I as the one obtained by the addition of unlabelled human IGF I. The dose-response curve obtained by canine IGF I paralleled the one obtained by human IGF I. Logit-log transformation and least squares fitting resulted in straight line fitting of the standard curve between 0.039 and 5 ng IGF I added per tube. The within-assay coefficient of variation (CV) was 16.7% and the between-assay CV was 21.8%. Plasma IGF I concentrations in normal dogs appeared to be a function of body size. The concentrations were 36 +/- 27 ng/ml in Cocker Spaniels, 87 +/- 33 ng/ml in Beagles, 117 +/- 34 ng/ml in Keeshonds, and 280 +/- 23 ng/ml in German Shepherds (mean +/- SEM). The mean IGF I level in a group of dogs with growth hormone (GH) elevation was 700 +/- 90 ng/ml. Though this group of dogs comprised both small and large dogs, the mean IGF I level significantly differed from the one found in German Shepherds, the largest breed studied (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367329     DOI: 10.1530/acta.0.1050294

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

1.  Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process.

Authors:  H M Brown-Borg; A M Bode; A Bartke
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

2.  Long-term growth hormone-releasing factor administration on growth hormone, insulin-like growth factor-I concentrations, and bone healing in the Beagle.

Authors:  P Dubreuil; T Abribat; B Broxup; P Brazeau
Journal:  Can J Vet Res       Date:  1996-01       Impact factor: 1.310

3.  Insulin-like growth factors and insulin: comparative aspects.

Authors:  E R Froesch; J Zapf
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

4.  Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1.

Authors:  L C Read; F J Ballard; G L Francis; R C Baxter; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

Review 5.  Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model.

Authors:  Steven Fleischer; Michele Sharkey; Katrina Mealey; Elaine A Ostrander; Marilyn Martinez
Journal:  AAPS J       Date:  2008-02-15       Impact factor: 4.009

6.  Relationship among insulin resistance, growth hormone, and insulin-like growth factor I concentrations in diestrous Swedish Elkhounds.

Authors:  E M Strage; M S Lewitt; J M Hanson; U Olsson; F Norrvik; I Lilliehöök; B S Holst; T Fall
Journal:  J Vet Intern Med       Date:  2014 Mar-Apr       Impact factor: 3.333

7.  A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?

Authors:  Imelda M McGonnell; Agamemnon E Grigoriadis; Eric W-F Lam; Joanna S Price; Andrew Sunters
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-20       Impact factor: 5.555

8.  Expression of Behavioural Traits in Goldendoodles and Labradoodles.

Authors:  Victoria L Shouldice; A Michelle Edwards; James A Serpell; Lee Niel; J Andrew B Robinson
Journal:  Animals (Basel)       Date:  2019-12-17       Impact factor: 2.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.